My RPRX Report Is Out Now... RRPX shares sliding
My Seekingalpha article on Repros Therapeutics (RPRX) was released yesterday, and the market is starting to sell the stock off this morning.
Here is the opening of the article:
“What's in a name? That which we call a rose, By any other word would smell as sweet.” -- William Shakespeare in Romeo and Juliet
Does an old discarded penny stock traded under a flashy new name smell sweeter to investors? Apparently so. Shares of Repros Therapeutics (RPRX) have risen sharply, more than doubling since September of last year. However, I wonder if many shareholders in Repros have forgotten, or maybe never learned, that Repros is the same corporation as the discredited and oft-sued Zonagen. In 2006, after numerous failures, Zonagen changed its name to Repros and hoped to shove two decades of failure under the rug"
Check out the full piece here, and if you are into shorting/buying options, join me in shorting RPRX.